SECOND ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) IN PATIENTS WITH RELAPSED LYMPHOMA AFTER FIRST ALLO-SCT. A RETROSPECTIVE STUDY OF THE EBMT LYMPHOMA WORKING PARTY

被引:0
|
作者
Horstmann, K. [1 ]
Boumendil, A. [2 ]
Finel, H. [3 ]
Apperley, J. F. [4 ]
Ciceri, F. [5 ]
Finke, J. [6 ]
Van Hoof, A. [7 ]
Ifrah, N. [8 ]
Kyrcz-Krzemien, S. [9 ]
Milone, G. [10 ]
Mufti, G. J. [11 ]
Or, R. [12 ]
Russell, N. H. [13 ]
Dreger, P. [1 ]
机构
[1] Univ Hosp Heidelberg, Heidelberg, Germany
[2] European Soc Blood & Marrow Transplantat, Istanbul, Turkey
[3] EBMT Lymphoma Working Party, Paris, France
[4] Hammersmith Hosp, London, England
[5] Ist Sci San Raffaele, I-20132 Milan, Italy
[6] Univ Med Ctr Freiburg, Freiburg, Germany
[7] Univ Hosp St Jan, Brugge, Belgium
[8] CHU Angers, Angers, France
[9] Med Univ Silesia, Katowice, Poland
[10] Grp Argentino Tratamiento Leucemia Aguda, Buenos Aires, DF, Argentina
[11] Kings Coll London, London WC2R 2LS, England
[12] Hadassah Hebrew Univ Med Ctr, Jerusalem, Israel
[13] City Hosp Nottingham, Nottingham, England
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
PH-P139
引用
收藏
页码:S167 / S167
页数:1
相关论文
共 50 条
  • [31] Ruxolitinib during Allogeneic Stem Cell Transplantation (allo-SCT) in Primary Myelofibrosis (PMF) Recommendation
    Tan, Yaxian
    Luo, Jie
    Zhou, Xuan
    Liu, Xiaoli
    Liu, Qifa
    Xu, Na
    BLOOD, 2020, 136
  • [32] Circulating endothelial progenitor cells in patients undergoing allogeneic transplantation (ALLO-SCT)
    Kideryova, Linda
    Vesela, Romana
    Hnatkova, Marketa
    Rychtrmocova, Hana
    Uchytilova, Lucie
    Benesova, Katerina
    Pytlik, Robert
    EXPERIMENTAL HEMATOLOGY, 2008, 36 (07) : S84 - S84
  • [33] Sequential Chemotherapy Followed by Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation (allo-SCT) in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML): A Survey From the Acute Leukemia Working Party of EBMT
    Ringden, Olle
    Labopin, Myriam
    Kolb, Hans Jochem
    Michallet, Mauricette
    Kroeger, Nicolaus
    Ganser, Arnold
    Bunjes, Donald
    Hallek, Michael
    Kanz, Lothar
    Schwerdtfeger, Rainer
    Holler, Ernst
    Arnold, Renate
    Huynh, Anne
    Nagler, Arnon
    Schmid, Christoph
    Mohty, Mohamad
    BLOOD, 2012, 120 (21)
  • [34] Contrasting Factors Determine the Kinetics of Disease Relapse after Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukaemia (AML): a Survey from the Acute Leukaemia Working Party of the EBMT
    Craddock, Charles
    Labopin, Myriam
    Socie, Gerard
    Huyn, Anne
    Deconinck, Eric
    Volin, Liisa
    Milpied, Noel
    Bourhis, Jean-Henri
    Rambaldi, Alessandro
    Chevallier, Patrice
    Cornelissen, Jan J.
    Blaise, Didier
    Maertens, Johann
    Schmid, Christoph
    Nagler, Arnon
    Mohty, Mohamad
    BLOOD, 2014, 124 (21)
  • [35] Gemcitabine, Fludarabine, and Melphalan for Reduced-Intensity Conditioning (RIC) and Allogeneic Stem Cell Transplantation (allo-SCT) for Relapsed/Refractory Hodgkin Lymphoma in the Brentuximab Vedotin Era
    Anderlini, P.
    Saliba, R.
    Ledesma, C.
    Plair, T.
    Alousi, A.
    Hosing, C.
    Khouri, I.
    Nieto, Y.
    Popat, U.
    Shpall, E.
    Fanale, M.
    Oki, Y.
    Neelapu, S.
    Younes, A.
    Champlin, R.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S70 - S71
  • [36] Fertility in Female Patients After Allogeneic Stem Cell Transplantation Following Reduced-Intensity Conditioning (RIC allo-SCT)
    Assouline, Emmanuelle
    Crocchiolo, Roberto
    Prebet, Thomas
    Furst, Sabine
    El-Cheikh, Jean
    Florence, Broussais
    Coso, Diane
    Charbonnier, Aude
    Chabannon, Christian
    Vey, Norbert
    Marc, Gamerre
    Blaise, Didier
    Courbiere, Blandine
    BLOOD, 2011, 118 (21) : 1318 - 1318
  • [37] AUTOLOGOUS STEM CELL TRANSPLANTATION (AUTO-SCT) IS HIGHLY EFFECTIVE IN RELAPSED NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA (NLPHL): A RETROSPECTIVE STUDY BY THE EBMT LYMPHOMA WORKING PARTY
    Akhtar, S.
    Boumendil, A.
    Finel, H.
    Masszi, T.
    Jindra, P.
    Nemet, D.
    Baurmann, H.
    Begiun, Y.
    Castagna, L.
    Ferrara, F.
    Foa, R.
    Malladi, R.
    Moraleda, J. M.
    Bloor, A.
    Salles, G.
    Meissner, J.
    Sureda, A.
    Dreger, P.
    HAEMATOLOGICA, 2016, 101 : 101 - 101
  • [38] UNRELATED DONOR (UD) ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) IN PRIMARY REFRACTORY ACUTE MYELOID LEUKEMIA (AML): REPORT OF 381 PATIENTS FROM THE ACUTE LEUKEMIA WORKING PARTY OF EBMT
    Brissot, E.
    Labopin, M.
    Stelljes, M.
    Ehninger, G.
    Schwerdtfeger, R.
    Zander, A. R.
    Mielke, S.
    Ganser, A.
    Finke, J.
    Schufer-Eckart, K.
    Bunjes, D.
    Kroeger, N.
    Schmid, C.
    Bethge, W. A.
    Kolb, H. J.
    Blau, I. W.
    Vitek, A.
    Bochtler, T.
    Meyer, R. G.
    Holler, E.
    Esteve, J.
    Nagler, A.
    Mohty, M.
    HAEMATOLOGICA, 2015, 100 : 13 - 14
  • [39] Endothelial Cell Complications after Allogeneic Stem Cell Transplantation, A Single Centre Analysis on 99 Consecutive Patients undergoing allo-sct
    Mancini, Giorgia
    Candelora, Matteo
    Urbano, Giuseppina
    Saraceni, Francesco
    Poiani, Monica
    Mariani, Marianna
    Federici, Irene
    Tarantino, Giuseppe
    Scortechini, Ilaria
    Olivieri, Attilio
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 599 - 599
  • [40] Allogeneic stem cell transplantation (Allo-SCT) for multiple myeloma (MM): The Mount Sinai experience.
    Afshar, Solmaz F.
    Galitzeck, Zachary
    Pineda-Roman, Mauricio
    Steinberg, Amir
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35